Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancer

BACKGROUND: Resistance to chemotherapy is the most common cause of treatment failure in acute myeloid leukemia (AML) and the drug efflux pump ABCB1 is a critical mediator. Recent studies have identified promoter translocations as common drivers of high ABCB1 expression in recurrent, chemotherapy-tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Mark S., Basma, Naseer J., Amaral, Fabio M. R., Williams, Gillian, Weightman, John P., Breitwieser, Wolfgang, Nelson, Louisa, Taylor, Stephen S., Wiseman, Daniel H., Somervaille, Tim C. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654162/
https://www.ncbi.nlm.nih.gov/pubmed/33167906
http://dx.doi.org/10.1186/s12885-020-07571-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654162/
https://www.ncbi.nlm.nih.gov/pubmed/33167906
http://dx.doi.org/10.1186/s12885-020-07571-0

Ejemplares similares